Item 5b UNODC, Drugs, Laboratory and Scientific Services Branch (DLSSB): Thank you, Mr. Chair. distinguished delegates, ladies and gentlemen, as you’re well aware that new psychoactive substances are not under international control, but they produce the same harmful effects as the ones we have under control. In just over a decade, the number of these …
From Plenary Sessions
Item 4. Strategic management, budgetary and administrative questions
UNODC: Thank you Mr. Chair. Notable progress has been made. We have taken robust institutional steps. Programs have been consolidated to improve efficiency. New frameworks have been developed such as a new regional framework for the Arab states to guide the office in better supporting the member states. Program delivery reached $383.9 million, an increase …
Side event: The new regulatory models of psychoactive substances in the grey zone – A new challenge or an opportunity?
Organized by Czechia with the support of Canada, Colombia, Mexico, Switzerland, the United States, the International Drug Policy Consortium and the Transnational Institute Jindrich Voboril – Czech Republic: Why is Czechia organising this event? The Czech Republic is a country with only 10,000,000 people in Central Europe, in the centre of the European Union. We …
Item 3. High-level segment (Friday evening)
India: India acknowledges the challenges and affirms its commitment to fight the global drug menace. Our diversity and federal structure recognises that drug control requires a multi-agency coordination. India has a strong commitment to the guiding principles of the three drug control conventions, the ECOSOC and the General Assembly. We maintain a zero tolerance policy …
Item 3. High-level segment (Friday afternoon)
Bangladesh: H. E. Ambassador Johnson, Chair of the Commission on Narcotic Drugs at its 67th Session, H. E. Ghada Waly, Executive Director of the UNODC, Excellencies, Distinguished delegates, Ladies and Gentlemen, Good afternoon. I begin by congratulating Ambassador Johnson and other members of the bureau and assure them of our full support. Mr. Chair, We …
Item 3. High-level segment (Friday morning)
Canada: Esteemed Chair, Ministers, Heads of Delegation, Distinguished Delegates, and Civil Society Representatives: Canada is experiencing one of the most serious public health crises in our country’s history: an unrelenting toxic drug and overdose crisis. The impact and scope of the toxic drug crisis is devastating and more complex than ever. Tragically, we have seen …